Skip to main content
  • Book
  • © 1990

Selective Activation of Drugs by Redox Processes

Editors:

Part of the book series: NATO Science Series A: (NSSA, volume 198)

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (31 chapters)

  1. Front Matter

    Pages i-xi
  2. Characteristics of Hypoxic Cells that Enhance their Susceptibility to Chemical Injury

    • Dean P. Jones, Tak Yee Aw, Xiaoqin Shan, Diane L. Tribble
    Pages 1-9
  3. Metal-Catalyzed Redox Processes in Biological Systems and Drug Activation

    • A. Breccia, E. Gattavecchia, E. Vecchi, E. Ferri
    Pages 25-37
  4. The Role of DNA Damage in the Bioreductive Action of 2-Nitroimidazoles

    • P. O’Neill, T. J. Jenner, O. Sapora, P. W. Crump, S. M. T. Cunniffe, E. M. Fielden
    Pages 53-61
  5. Redox Activation of Drugs by the Red Blood Cell Membrane

    • J. Z. Pedersen, L. Rossi, L. Marcocci, I. Mavelli, G. Rotilio
    Pages 89-95
  6. Nitroacridines and Nitroquinolines as DNA-Affinic Hypoxia-Selective Cytotoxins

    • William A. Denny, William R. Wilson, Graham J. Atwell, Maruta Boyd, Susan M. Pullen, Robert F. Anderson
    Pages 149-158
  7. Metabolic Effects of Hypoxic Cell Sensitizers

    • Christian Streffer, Peter Tamulevicius
    Pages 159-164
  8. Does Ro 03–8799 Concentration in Human Tumour Xenografts Predict Radiosensitization? Comparison with SR-2508

    • Marcelle Guichard, Alphonse Taghian, Francoise Lespinasse, Edmond Philippe Malaise
    Pages 165-172
  9. Enzyme-Directed Bioreductive Drug Development

    • Paul Workman, Michael I. Walton
    Pages 173-191
  10. Improved Treatment of Tumours in vivo by Combining the Bioreductive Drug RSU-1069, Hydralazine and Hyperthermia

    • Michael R. Horsman, Kent L. Christensen, David J. Chaplin, Jens Overgaard
    Pages 193-202
  11. The Assessment of Bioreductive Drug Toxicity in vitro and in Experimental Tumours in vivo

    • I. J. Stratford, G. E. Adams, J. C. M. Bremner, S. Cole, Li Ding, H. Edwards et al.
    Pages 203-212

Editors and Affiliations

  • MRC Radiobiology Unit, Chilton, Oxon., UK

    G. E. Adams, E. M. Fielden

  • Facoltà di Farmacia, Istituto di Scienze Chimiche, Università Degli Studi di Bologna, Bologna, Italy

    A. Breccia

  • CRC Gray Laboratory, Mount Vernon Hospital, Middlesex, UK

    P. Wardman

Bibliographic Information

  • Book Title: Selective Activation of Drugs by Redox Processes

  • Editors: G. E. Adams, A. Breccia, E. M. Fielden, P. Wardman

  • Series Title: NATO Science Series A:

  • DOI: https://doi.org/10.1007/978-1-4615-3768-7

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Plenum Press, New York 1990

  • Hardcover ISBN: 978-0-306-43735-9Published: 28 February 1991

  • Softcover ISBN: 978-1-4613-6679-9Published: 21 October 2012

  • eBook ISBN: 978-1-4615-3768-7Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XI, 361

  • Topics: Oncology, Pharmacology/Toxicology, Biochemistry, general

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access